ASK1 modulators (CJ Healthcare)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameASK1 modulators (CJ Healthcare)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis signal-regulating kinase 1 modulators
TargetsApoptosis signal-regulating kinase 1
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHK Inno N Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHK Inno N Corp
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A